Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.
Liying ZhouQing LiJingshen XuShuaikang WangZhiqiang SongXinyi ChenYan MaZhiguang LinBobin ChenHe HuangPublished in: Neuro-oncology advances (2022)
We developed a logical regression model based on metabolic markers in CSF that can effectively predict PCNSL patient prognosis before the HD-MTX-based chemotherapy treatments.